Meningococcal group acwy conjugate-group b vaccine (cvx 328) Disease Interactions
There are 2 disease interactions with meningococcal group acwy conjugate-group b vaccine (cvx 328).
Meningococcal conjugate vaccine (applies to meningococcal group acwy conjugate-group b vaccine (cvx 328)) GBS
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Guillain-Barre Syndrome
Persons previously diagnosed with Guillain-Barre syndrome (GBS) may be at increased risk of GBS following receipt of meningococcal conjugate vaccine. The decision to give this vaccine should take into account the potential benefits and risks.
References (2)
- (2024) "Product Information. Penbraya (cvx 316) (meningococcal group ACWY conjugate-group B vaccine (cvx 316))." Pfizer U.S. Pharmaceuticals Group
- (2025) "Product Information. Penmenvy (cvx 328) (meningococcal group ACWY conjugate-group B vaccine (cvx 328))." GlaxoSmithKline
Vaccines (live attenuated/toxoid) (applies to meningococcal group acwy conjugate-group b vaccine (cvx 328)) immunocompromised
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Immunodeficiency
The expected antibody responses may not be obtained when live attenuated vaccines and/or toxoids are administered to immunosuppressed persons, including those receiving immunosuppressive therapy. Caution and close monitoring is advised.
References (9)
- (2005) "Product Information. Menactra (meningococcal conjugate vaccine)." sanofi pasteur
- (2022) "Product Information. ActHIB (Hib) (haemophilus b conjugate (PRP-T) vaccine)." sanofi pasteur
- (2022) "Product Information. Bexsero (meningococcal group B vaccine)." Novartis Vaccines & Diagnostics Inc
- (2022) "Product Information. Trumenba (meningococcal group B vaccine)." Pfizer U.S. Pharmaceuticals Group
- (2022) "Product Information. Hiberix (Hib) (haemophilus b conjugate (PRP-T) vaccine)." GlaxoSmithKline
- (2016) "Product Information. Vaxchora (cholera vaccine, live)." PaxVax
- (2022) "Product Information. Vaxchora (cholera vaccine, live)." Emergent Travel Health, Inc
- (2023) "Product Information. Ixchiq (cvx 317) (chikungunya vaccine, live (cvx 317))." Valneva USA
- (2025) "Product Information. Penmenvy (cvx 328) (meningococcal group ACWY conjugate-group B vaccine (cvx 328))." GlaxoSmithKline
Switch to consumer interaction data
Meningococcal group acwy conjugate-group b vaccine (cvx 328) drug interactions
There are 303 drug interactions with meningococcal group acwy conjugate-group b vaccine (cvx 328).
Report options
More about meningococcal group acwy conjugate-group b vaccine (cvx 328)
- meningococcal group acwy conjugate-group b vaccine (cvx 328) consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- Drug class: bacterial vaccines
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.